Canada markets close in 15 minutes

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1889+0.0008 (+0.43%)
As of 03:33PM EST. Market open.

Agile Therapeutics, Inc.

500 College Road East
Suite 310
Princeton, NJ 08540
United States
609 683 1880
https://www.agiletherapeutics.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees30

Key Executives

NameTitlePayExercisedYear Born
Mr. Alfred F. AltomariChairman & CEO804.82kN/A1959
Mr. Geoffrey P. GilmoreChief Admin. Officer555.21kN/A1966
Dr. Paul Korner M.B.A., M.D.Sr. VP & Chief Medical Officer574.59kN/A1966
Mr. Jason ButchPrincipal Financial Officer, VP & Chief Accounting OfficerN/AN/AN/A
Matthew RileyHead of Investor Relations & Corp. CommunicationsN/AN/AN/A
Mr. Robert G. Conway M.E.Chief Corp. Planning & Supply Chain OfficerN/AN/A1957
Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.ConsultantN/AN/A1968
Ms. Amy WelshChief Commercial OfficerN/AN/AN/A
Joseph D'UrsoControllerN/AN/AN/A
Dr. Kathryn MacFarlane Pharm.D.AdvisorN/AN/A1966
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of December 1, 2022 is 7. The pillar scores are Audit: 7; Board: 7; Shareholder Rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.